iSpecimen Inc. Operating Lease Right-of-Use Assets
iSpecimen Inc. (ISPC) had Operating Lease Right-of-Use Assets of $238.39 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $238.39K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $253.91K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $269.16K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $284.15K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $238.39K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $253.91K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $269.16K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $284.15K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $299.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $313.61K 10-Q · filed 2025-05-19 |
| 2024-12-31 | $327.98K 10-K · filed 2026-04-01 |
| 2024-09-30 | $342.11K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $26.54K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $153.34K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $193.86K 10-K · filed 2025-04-14 |
| 2023-09-30 | $233.81K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $107.11K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $146.19K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $184.69K 10-K · filed 2024-03-13 |
| 2022-09-30 | $222.63K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $260.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $296.83K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |